1	In	In	B-PP	IN	O	11	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	11	P
4	blood	blood	B-NP	NN	B-cell_type	5	NMOD
5	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	11	SUB
6	from	from	B-PP	IN	O	5	NMOD
7	patients	patient	B-NP	NNS	O	6	PMOD
8	with	with	B-PP	IN	O	7	NMOD
9	granulomatous	granulomatous	B-NP	JJ	O	10	NMOD
10	diseases	disease	I-NP	NNS	O	8	PMOD
11	did	do	B-VP	VBD	O	0	ROOT
12	not	not	I-VP	RB	O	11	VMOD
13	express	express	I-VP	VB	O	11	VC
14	detectable	detectable	B-NP	JJ	O	22	NMOD
15	1	1	I-NP	CD	B-protein	22	NMOD
16	,	,	I-NP	,	I-protein	22	P
17	25	25	I-NP	CD	I-protein	22	NMOD
18	(	(	O	(	I-protein	22	NMOD
19	OH	OH	B-NP	NN	I-protein	22	NMOD
20	)	)	O	)	I-protein	22	NMOD
21	2D3	2D3	B-NP	NN	I-protein	22	NMOD
22	receptors	receptor	I-NP	NNS	I-protein	13	OBJ
23	.	.	O	.	O	11	P

1	The	The	B-NP	DT	O	2	NMOD
2	proband	proband	I-NP	NN	O	3	SUB
3	had	have	B-VP	VBD	O	0	ROOT
4	no	no	B-NP	DT	O	7	NMOD
5	detectable	detectable	I-NP	JJ	O	7	NMOD
6	DPD	DPD	I-NP	NN	B-protein	7	NMOD
7	activity	activity	I-NP	NN	O	3	OBJ
8	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	16	VMOD
2	nonerythroid	nonerythroid	B-NP	JJ	B-cell_line	4	NMOD
3	HL-60	HL-60	I-NP	NN	I-cell_line	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_line	1	PMOD
5	in	in	B-PP	IN	O	4	NMOD
6	which	which	B-NP	WDT	O	5	PMOD
7	the	the	B-NP	DT	O	9	NMOD
8	HS2	HS2	I-NP	NN	B-DNA	9	NMOD
9	enhancer	enhancer	I-NP	NN	I-DNA	10	SUB
10	is	be	B-VP	VBZ	O	5	SBAR
11	inactive	inactive	B-NP	JJ	O	10	PRD
12	,	,	I-NP	,	O	16	P
13	long	long	I-NP	JJ	B-RNA	15	NMOD
14	enhancer	enhancer	I-NP	NN	I-RNA	15	NMOD
15	transcripts	transcript	I-NP	NNS	I-RNA	16	SUB
16	are	be	B-VP	VBP	O	0	ROOT
17	not	not	O	RB	O	16	VMOD
18	detectable	detectable	B-ADJP	JJ	O	16	PRD
19	.	.	O	.	O	16	P

1	He	He	B-NP	PRP	O	2	SUB
2	felt	feel	B-VP	VBD	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	no	no	B-NP	DT	O	6	NMOD
5	specific	specific	I-NP	JJ	O	6	NMOD
6	therapy	therapy	I-NP	NN	O	7	SUB
7	was	be	B-VP	VBD	O	3	SBAR
8	available	available	B-ADJP	JJ	O	11	NMOD
9	regarding	regard	B-NP	VBG	O	11	NMOD
10	Moebius	Moebius	I-NP	NNP	O	11	NMOD
11	sequence	sequence	I-NP	NN	O	7	PRD
12	.	.	O	.	O	2	P

1	I	I	B-NP	PRP	O	2	SUB
2	do	do	B-VP	VBP	O	0	ROOT
3	not	not	I-VP	RB	O	2	VMOD
4	recommend	recommend	I-VP	VB	O	2	VC
5	drug	drug	B-NP	NN	O	6	NMOD
6	treatment	treatment	I-NP	NN	O	4	OBJ
7	for	for	B-PP	IN	O	6	NMOD
8	stone	stone	B-NP	NN	O	9	NMOD
9	prevention	prevention	I-NP	NN	O	7	PMOD
10	.	.	O	.	O	2	P

1	If	If	B-SBAR	IN	O	14	VMOD
2	her	her	B-NP	PRP$	O	3	NMOD
3	pain	pain	I-NP	NN	O	4	SUB
4	should	should	B-VP	MD	O	1	SBAR
5	not	not	I-VP	RB	O	4	VMOD
6	have	have	I-VP	VB	O	4	VC
7	been	be	I-VP	VBN	O	6	VC
8	resolved	resolve	I-VP	VBN	O	7	VC
9	by	by	B-PP	IN	O	8	VMOD
10	that	that	B-NP	DT	O	11	NMOD
11	time	time	I-NP	NN	O	9	PMOD
12	,	,	O	,	O	14	P
13	there	there	B-NP	EX	O	14	SUB
14	is	be	B-VP	VBZ	O	0	ROOT
15	the	the	B-NP	DT	O	16	NMOD
16	possibility	possibility	I-NP	NN	O	14	PRD
17	of	of	B-PP	IN	O	16	NMOD
18	repeating	repeat	B-VP	VBG	O	17	PMOD
19	facet	facet	B-NP	JJ	O	20	NMOD
20	rhizotomy	rhizotomy	I-NP	NN	O	18	OBJ
21	.	.	O	.	O	14	P

1	She	She	B-NP	PRP	O	2	SUB
2	denies	deny	B-VP	VBZ	O	0	ROOT
3	any	any	B-NP	DT	O	5	NMOD
4	ear	ear	I-NP	JJ	O	5	NMOD
5	pain	pain	I-NP	NN	O	16	NMOD
6	,	,	O	,	O	16	P
7	sore	sore	B-NP	NN	O	8	NMOD
8	throat	throat	I-NP	NN	O	16	NMOD
9	,	,	O	,	O	16	P
10	odynophagia	odynophagia	B-NP	NN	O	16	NMOD
11	,	,	O	,	O	16	P
12	hemoptysis	hemoptysis	B-NP	NN	O	16	NMOD
13	,	,	O	,	O	16	P
14	shortness-of-breath	shortness-of-breath	B-NP	NN	O	16	NMOD
15	,	,	O	,	O	16	P
16	dyspnea	dyspnea	B-NP	NN	O	33	NMOD
17	on	on	B-PP	IN	O	16	NMOD
18	exertion	exertion	B-NP	NN	O	17	PMOD
19	,	,	O	,	O	33	P
20	chest	chest	B-NP	NN	O	21	NMOD
21	discomfort	discomfort	I-NP	NN	O	33	NMOD
22	,	,	O	,	O	33	P
23	anorexia	anorexia	B-NP	NN	O	33	NMOD
24	,	,	O	,	O	33	P
25	nausea	nausea	B-NP	NN	O	33	NMOD
26	,	,	O	,	O	33	P
27	weight-loss	weight-loss	B-NP	NN	O	33	NMOD
28	,	,	O	,	O	33	P
29	mass	mass	B-NP	NN	O	33	NMOD
30	,	,	O	,	O	33	P
31	adenopathy	adenopathy	B-NP	NN	O	33	NMOD
32	or	or	I-NP	CC	O	33	NMOD
33	pain	pain	I-NP	NN	O	2	OBJ
34	.	.	O	.	O	2	P

1	However	However	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	I	I	B-NP	PRP	O	4	SUB
4	suspect	suspect	B-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	her	her	B-NP	PRP$	O	7	NMOD
7	pain	pain	I-NP	NN	O	8	SUB
8	is	be	B-VP	VBZ	O	5	SBAR
9	not	not	O	RB	O	8	VMOD
10	due	due	B-ADJP	JJ	O	8	PRD
11	to	to	B-PP	TO	O	10	AMOD
12	an	an	B-NP	DT	O	15	NMOD
13	underlying	underlie	I-NP	VBG	O	15	NMOD
14	neurologic	neurologic	I-NP	JJ	O	15	NMOD
15	disorder	disorder	I-NP	NN	O	11	PMOD
16	.	.	O	.	O	4	P

1	He	He	B-NP	PRP	O	2	SUB
2	has	have	B-VP	VBZ	O	0	ROOT
3	no	no	B-NP	DT	O	4	NMOD
4	problem	problem	I-NP	NN	O	2	OBJ
5	doing	do	B-VP	VBG	O	4	NMOD
6	sth	sth	B-NP	NN	O	5	OBJ
7	.	.	O	.	O	2	P

1	Neither	Neither	B-NP	DT	O	4	NMOD
2	John	John	B-NP	NNP	O	4	NMOD
3	nor	nor	O	CC	O	4	NMOD
4	Betty	Betty	B-NP	NNP	O	5	SUB
5	is	be	B-VP	VBZ	O	0	ROOT
6	at	at	B-PP	IN	O	5	PRD
7	home	home	B-NP	NN	O	6	PMOD
8	.	.	O	.	O	5	P

1	It	It	B-NP	PRP	O	2	SUB
2	can	can	B-VP	MD	O	0	ROOT
3	not	not	I-VP	RB	O	2	VMOD
4	rule	rule	I-VP	VB	O	2	VC
5	out	out	B-PRT	RP	O	4	VMOD
6	the	the	B-NP	DT	O	7	NMOD
7	possibility	possibility	I-NP	NN	O	4	OBJ
8	that	that	B-SBAR	IN	O	7	NMOD
9	he	he	B-NP	PRP	O	10	SUB
10	is	be	B-VP	VBZ	O	8	SBAR
11	still	still	B-ADVP	RB	O	10	VMOD
12	in	in	B-PP	IN	O	10	VMOD
13	danger	danger	B-NP	NN	O	12	PMOD
14	.	.	O	.	O	2	P

1	Molecular	Molecular	B-NP	JJ	O	3	NMOD
2	fragile-X	fragile-X	I-NP	NN	O	3	NMOD
3	results	result	I-NP	NNS	O	4	SUB
4	reveal	reveal	B-VP	VBP	O	0	ROOT
5	no	no	B-NP	DT	O	9	NMOD
6	apparent	apparent	I-NP	JJ	O	9	NMOD
7	PMR-1	PMR-1	I-NP	NN	O	9	NMOD
8	gene	gene	I-NP	NN	O	9	NMOD
9	abnormality	abnormality	I-NP	NN	O	4	OBJ
10	.	.	O	.	O	4	P

1	She	She	B-NP	PRP	O	2	SUB
2	denies	deny	B-VP	VBZ	O	0	ROOT
3	any	any	B-NP	DT	O	4	NMOD
4	blood	blood	I-NP	NN	O	2	OBJ
5	in	in	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	7	NMOD
7	stool	stool	I-NP	NN	O	5	PMOD
8	.	.	O	.	O	2	P

1	Mrs.	Mrs.	B-NP	NNP	O	3	NMOD
2	Jane	Jane	I-NP	NNP	O	3	NMOD
3	Doe	Doe	I-NP	NNP	O	4	SUB
4	returns	return	B-VP	VBZ	O	0	ROOT
5	with	with	B-PP	IN	O	4	VMOD
6	no	no	B-NP	DT	O	7	NMOD
7	complaints	complaint	I-NP	NNS	O	5	PMOD
8	worrisome	worrisome	B-VP	VBP	O	4	VMOD
9	for	for	B-PP	IN	O	8	VMOD
10	recurrent	recurrent	B-NP	JJ	O	14	NMOD
11	or	or	I-NP	CC	O	14	NMOD
12	metastatic	metastatic	I-NP	JJ	O	14	NMOD
13	oropharynx	oropharynx	I-NP	NN	O	14	NMOD
14	cancer	cancer	I-NP	NN	O	9	PMOD
15	.	.	O	.	O	4	P

1	She	She	B-NP	PRP	O	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	not	not	I-VP	RB	O	2	VMOD
4	having	have	I-VP	VBG	O	2	VC
5	any	any	B-NP	DT	O	8	NMOD
6	incontinence	incontinence	I-NP	NN	O	8	NMOD
7	or	or	I-NP	CC	O	8	NMOD
8	suggestion	suggestion	I-NP	NN	O	4	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	infection	infection	B-NP	NN	O	9	PMOD
11	at	at	B-PP	IN	O	4	VMOD
12	this	this	B-NP	DT	O	13	NMOD
13	time	time	I-NP	NN	O	11	PMOD
14	.	.	O	.	O	2	P

